Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126820541 | 12682054 | 1 | I | 2016 | 20160818 | 20160824 | 20160824 | EXP | CA-ABBVIE-16P-028-1708495-00 | ABBVIE | 0.00 | F | Y | 59.02000 | KG | 20160824 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126820541 | 12682054 | 1 | PS | LUPRON DEPOT | LEUPROLIDE ACETATE | 1 | Intramuscular | UNKNOWN | 20708 | 11.25 | MG | POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION | |||||||
| 126820541 | 12682054 | 2 | C | IRON | IRON | 1 | Other | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126820541 | 12682054 | 1 | Endometriosis |
| 126820541 | 12682054 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126820541 | 12682054 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126820541 | 12682054 | Drug ineffective | |
| 126820541 | 12682054 | Menstruation delayed | |
| 126820541 | 12682054 | Vaginal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126820541 | 12682054 | 1 | 20160725 | 0 |